Epizyme (EPZM) Tops Q1 EPS by 23c, Revenues Miss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall St treads water as chips rise, megacaps fall ahead of Fed, Big Tech earnings
- SK Hynix shares surge after Q3 profit beats expectations
- Oil prices rise about 2% as Yemen fighting stokes supply fears
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
Epizyme Reports Business Progress and First Quarter 2020 Financial Results
May 4, 2020 6:30 AM EDTTAZVERIK Successfully Launched for First Approved Indication; PDUFA Date of June 18, 2020 for sNDA for Follicular Lymphoma Indication
Business Continuity Plans in Place in Response to COVID-19
Conference Call to be Held Today, May 4 at 9:00 a.m. ET
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Epizyme, (Nasdaq: EPZM), a fully integrated, commercial-stage... More



